Spoliation Hearing Granted In Lexapro Patent Suit

Law360, New York (April 15, 2009, 12:00 AM EDT) -- A federal district judge has granted a spoliation hearing to determine whether Forest Laboratories Inc. improperly destroyed key documents related to its infringement suit against Caraco Pharmaceutical Laboratories Ltd. over a patent for the depression treatment Lexapro.

Judge Bernard A. Friedman of the U.S. District Court for the Eastern District of Michigan on Tuesday ordered that the hearing would determine whether Forest destroyed electronic records that were otherwise available and that it knew contained documents of key players to the litigation, and if so, whether Forest...
To view the full article, register now.